Efficacy of an Alpha-Blocker for the Treatment of Nonneurogenic Voiding Dysfunction in Women: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial.

Young-Suk LeeKyu-Sung LeeMyung-Soo ChooJoon Chul KimJeong Gu LeeJu Tae SeoJeong Zoo LeeJi Youl LeeSeung-June OhYong Gil Na

Published in: International neurourology journal (2018)

Alfuzosin might not be more effective than placebo for treating FVD. The presence or the grade of BOO did not affect the results. A further study with sufficient power is needed to determine the efficacy of α1-AR blockers for the treatment of FVD.

Keyphrases

double blind
placebo controlled
clinical trial
phase iii
open label
oxidative stress
adipose tissue
insulin resistance
polycystic ovary syndrome
pregnant women